JLB & Associates Inc. Trims Stock Position in Genpact Limited (NYSE:G)

JLB & Associates Inc. cut its holdings in Genpact Limited (NYSE:G - Free Report) by 31.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 36,836 shares of the business services provider's stock after selling 16,644 shares during the quarter. JLB & Associates Inc.'s holdings in Genpact were worth $1,856,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Atlas Capital Advisors Inc. lifted its position in shares of Genpact by 55.8% in the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after purchasing an additional 216 shares during the period. Stifel Financial Corp raised its stake in Genpact by 1.0% in the fourth quarter. Stifel Financial Corp now owns 30,821 shares of the business services provider's stock worth $1,324,000 after buying an additional 291 shares in the last quarter. CIBC Asset Management Inc lifted its holdings in Genpact by 5.5% during the fourth quarter. CIBC Asset Management Inc now owns 5,692 shares of the business services provider's stock worth $244,000 after buying an additional 297 shares during the period. Fifth Third Bancorp boosted its position in Genpact by 9.5% during the 1st quarter. Fifth Third Bancorp now owns 3,461 shares of the business services provider's stock valued at $174,000 after acquiring an additional 299 shares in the last quarter. Finally, OneAscent Wealth Management LLC increased its holdings in shares of Genpact by 5.5% in the 4th quarter. OneAscent Wealth Management LLC now owns 8,380 shares of the business services provider's stock valued at $360,000 after acquiring an additional 439 shares during the period. 96.03% of the stock is currently owned by institutional investors.

Genpact Stock Down 3.5%

G stock traded down $1.48 on Friday, hitting $40.63. 4,402,223 shares of the company's stock were exchanged, compared to its average volume of 1,599,766. The firm has a 50 day moving average price of $45.22 and a two-hundred day moving average price of $47.02. Genpact Limited has a 12-month low of $30.38 and a 12-month high of $56.76. The stock has a market cap of $7.10 billion, a P/E ratio of 13.87, a price-to-earnings-growth ratio of 1.59 and a beta of 0.94. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.45 and a current ratio of 2.45.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. Genpact had a return on equity of 22.35% and a net margin of 10.88%. The business had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. During the same quarter last year, the company earned $0.73 earnings per share. The company's quarterly revenue was up 7.4% on a year-over-year basis. As a group, equities research analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Wednesday, June 18th will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Wednesday, June 18th. This represents a $0.68 annualized dividend and a dividend yield of 1.67%. Genpact's payout ratio is currently 23.21%.

Insider Activity

In other Genpact news, Director Nicholas C. Gangestad acquired 2,000 shares of the firm's stock in a transaction on Tuesday, May 13th. The stock was acquired at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the purchase, the director now owns 2,000 shares in the company, valued at approximately $87,940. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 3.07% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on G. Wall Street Zen upgraded Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. Robert W. Baird reduced their target price on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Finally, Needham & Company LLC decreased their price target on shares of Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research report on Thursday, May 8th. Four analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $50.71.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.